ASSESSING THE POSSIBILITY TO APPLY THE FIBRIN GLuE BY CORd BLOOd PLASMA AS A SCAFFOLd FOR MESENCHYMAL STEM CELLS TRANSPLANTATION

Cover Page

Cite item

Full Text

Abstract

Mesenchymal stem cells (MSCs) and pre-chondrocytes (MSK-Ch) derived from them are an ef- fective tool for the restoration and maintenance of joint cartilage. This approach is based on the use of MSCs as a) chondrocyte precursor to form a cartilaginous implant, b) producing a large number of bioactive factors in the area of implantation. delivery of MSC and MSC-Ch into the damaged joint can be achieved by the implantation of scaffold with cells to ensure retention of the cells at the injection site and an additional supply of cells of biologically active substances.Scaffold based on fibrin glue (FG) are promising because of the high biocompatibility, biodegrad- ability, ease of use. FG cryoprecipitate of autologous plasma (Au-FG) patient or allogeneic umbili- cal cord blood plasma (uCB-FG) in some cases may be regarded as a preferred embodiment of ready commercial products. The advantages of the Au-FG are to minimize the side effects, risks of infection and the occurrence of allergic reactions, availability and reduced cost of the procedure. uCB-FG is enriched with biologically active substances and derived from byproduct during collection stem cells from the cord blood.We have developed a protocol that allows to obtain FG in a closed system throughout the entire process of blood sampling until the transplant procedure, which makes it possible clinical application of the Au-FG and uCB-FG. Also shown that cultivation in Au-FG and uCB-FG does not change the immunophenotype of cells and the level of their proliferation and has a stimulating effect on chondro- genic differentiation.

About the authors

N I Enukashvily

СЗГМУб НИЛ клеточных технологий; Институт цитологии РАН

A A Aizenshtadt

ООО «Покровский банк стволовых клеток» СЗГМУб НИЛ клеточных технологий

V V Bagaeva

ООО «Покровский банк стволовых клеток»

O V Supilnikova

ООО «Покровский банк стволовых клеток» СЗГМУб НИЛ клеточных технологий

D A Ivolgin

ООО «Покровский банк стволовых клеток» СЗГМУб НИЛ клеточных технологий

I I Maslennikova

ООО «Покровский банк стволовых клеток» СЗГМУб НИЛ клеточных технологий

S V Novikova

ООО «Покровский банк стволовых клеток»

Sh F Adylov

ООО «Покровский банк стволовых клеток»

References

  1. Pittenger M.F. Multilineage potential of adult human mesenchymal stem cells / Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. // Science. - 1999. - 284 (5411). - P. 1437.
  2. Barry F.P. Mesenchymal stem cells: clinical applications and biological characterization / Barry F.P., Murphy J.M. // Int J Biochem Cell Biol. - 2004. - Vol. 36. - Issue 4. - P. 568584.
  3. Heng B.C. Directing stem cell differentiation into the chondrogenic lineage in vitro / Heng B.C. [et al] //Stem Cells. - 2004. - Vol. 22 (7). - P. 115267.
  4. Solchaga L.A. Chondrogenic differentiation of bone marrowderived mesenchymal stem cells: tips and tricks / Solchaga L.A., Penick K.J., Welter J.F. // Methods Mol Biol. - 2011. - Vol. 698. - P. 253278.
  5. Wagner W. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood / Wagner W. [et al] // Exp Hematol. - 2005. - Vol. 33 (11). - P. 14021416.
  6. Jin H.J. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy /Jin H.J. [et al] // Int J Mol Sci. - 2013. - Vol. 3; 14 (9). - P. 179868001.
  7. Айзенштадт А.А. Сравнение пролиферативной активности и фенотипа МСК, полученных из костного мозга, жировой ткани и пупочного канатика / Айзенштадт А.А. [и др]// Вестник СевероЗападного государственного медицинского университета им. И.И. Мечникова, 2015. - № 2. - С. 1422.
  8. Slaughter B.V. Hydrogels in regenerative medicine / Slaughter [et al] // Adv Mater. - 2009. - Vol. 21 (3233) - P. 330729.
  9. Jockenhoevel S. Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering / Jockenhoevel S. [et al] // Eur J Cardiothorac Surg. - 2001. - Vol. 4 - P. 42430.
  10. Swartz D.D. Engineering of fibrinbased functional and implantable smalldiameter blood vessels/ Swartz D.D. [et al]// Am J Physiol Heart Circ Physiol. - 2005. - Vol. 288 (3). - P. 145160.
  11. Ahmed T.A. Fibrin: a versatile scaffold for tissue engineering applications// Ahmed T.A. [et al] // Tissue Eng Part B Rev. - 2008. - Vol. 14 (2) - P. 199215.
  12. Phadnis S.M. Human umbilical cord blood serum promotes growth, proliferation, as well as differentiation of human bone marrowderived progenitor cells/ Phadnis S.M. [et al] // In Vitro Cell Dev Biol Anim. - 2006. - Vol. 42 (10). - P. 283286.
  13. Tekkatte С. "Humanized" stem cell culture techniques: the animal serum controversy / Tekkatte C. [et al] // Stem Cells Int. - 2011. - Vol. 2011. - P. 504723.
  14. Pereira T. (2014) MSCs Conditioned Media and Umbilical Cord Blood Plasma Metabolomics and Composition. / Pereira T. [et al.] // PLoS ONE. - 2014 - Vol. 9 (11): - e113769.
  15. Wiedemann M. Neonatal blood plasma is less susceptible to oxidation than adult plasma owing to its higher content of bilirubin and lower content of oxidizable Fatty acids. / Wiedemann M. [et al] // Pediatr Res. - 2003 - Vol. 53 (5) - P. 843849.
  16. TegerNilsson A.C. Fibrinogen to fibrin transformation in umbilical cord blood and purified neonatal fibrinogen./ TegerNilsson A.C. [et al]// Thromb Res. - 1974 - Vol. 5 (5) - P. 601612.
  17. Foley M.E. Viscosity, haematocrit, fibrinogen and plasma proteins in maternal and cord blood / Foley M.E. [et al] // Br J Obstet Gynaecol. - 1978. - Vol. 85 (7). - P. 5004.
  18. Mosesson M.W. The ultrastructure of fibrinogen420 and the fibrin420 clot. / Mosessen M.W. [et al.] // Biophysical Chemistry - 2004 - Vol. 112 - P. 209214.
  19. Hamulyak K. Reevaluation of some properties of fibrinogen, purified from cord blood of normal newborns / Hmulyak K. [et al] // Thromb Res. - 1983. - Vol. 32 (3). - P. 30110.
  20. Pool J.G. Experiences in the preparation of AHG concentrates from human plasma./ Pool J.G., Hink JH// Bibl Haematol. - 1964 - Vol. 19 - P. 14650.
  21. Brecher M. America Association of Blood Banks Technical Manual. Methods 6.11, 6.12 / Brecher M. / AABB, 15th Edition - 2005. - Chapter 3. - P. 81415.
  22. Момот А.П. Патология гемостаза. Принципы и алгоритмы клиниколабораторной диагностики/ Момот А.П. // СПб., ФормаТ - 2006. - Стр. 208.
  23. Radosevich M. Fibrin sealant: Scientific rationale, production methods, properties, and current clinical / Radosevich [et al] // Vox Sang. - 1997 - Vol. 72 - P. 133143.
  24. Lee O.K. Fibrin glue as a vehicle for mesenchymal stem cell delivery in bone regeneration/ Lee O.K. [et al]// J Chin Med Assoc. - 2008. - Vol. 71 (2). - P. 5961.
  25. Ho W. The Behavior of Human Mesenchymal Stem Cells in 3D Fibrin Clots: Dependence on Fibrinogen Concentration and Clot Structure Tissue Engineering./ Ho [et al] - 2006. - Vol. 12 (6) - P. 1587.
  26. Isogai N. Experimental use of fibrin glue to induce sitedirected osteogenesis from cultured periosteal cells // Isogai N. [et al] // Plast Reconstr Surg. - 2000. - Vol. 105 (3). - P. 95363.
  27. Wu X. Fibrin glue as the celldelivery vehicle for mesenchymal stromal cells in regenerative medicine/ Wu X. [et al] // The Journal of Cell Therapy. Cytotherapy - 2012. - Vol. 14 (5). - P. 555562.
  28. Wang K. Fibrin glue with autogenic bone marrow mesenchymal stem cells for urethral injury repair in rabbit model / Wang K. [et al] // Tissue Eng Part A. - 2012. - Vol. 18 (2324). - P. 250717.
  29. Scotti C. Engineering human cellbased, functionally integrated osteochondral grafts by biological bonding of engineered cartilage tissues to bony scaffolds / Scotti C. [et al] // Biomaterials. - 2010. - Vol. 31 (8). - P. 22529.
  30. Germain L. Fibrin hydrogels to deliver dental stem cells of the apical papilla for regenerative medicine / Germain L. [et al] // Regen Med. - 2015. - Vol. 10 (2). - P. 15367.

Copyright (c) 2017 Enukashvily N.I., Aizenshtadt A.A., Bagaeva V.V., Supilnikova O.V., Ivolgin D.A., Maslennikova I.I., Novikova S.V., Adylov S.F.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies